(Total Views: 517)
Posted On: 01/15/2022 3:20:25 PM
Post# of 148902
interesting about so. korea they already have a mab regdanvimab by celltrion but not close to what leronlimab can offer.
https://www.biopharma-reporter.com/Article/20...antibodies
https://www.biopharma-reporter.com/Article/20...antibodies
(0)
(0)Scroll down for more posts ▼
